The Global Centre for Risk and Innovation (GCRI)
Biomanufacturing uses cells, enzymes and microorganisms to make products at scale: medicines and vaccines, food ingredients, chemicals and materials. It can reduce dependence on fossil feedstocks and shorten supply chains, but it brings its own process safety, quality and supply risks. This topic, studied at Biotechnology and Biosecurity, a platform of The Global Centre for Risk and Innovation (GCRI), examines industrial biology as a production system and the risks that come with scaling it up.
GCRI · In development · service level R0
Biomanufacturing is the industrial production of materials, chemicals, food ingredients and medicines using living cells or their components. This page covers the risks that matter for resilience: process safety, quality and regulatory oversight, concentration of capacity in few sites, and the supply of inputs and skills. It describes institutional capacity and supply-chain exposure, not production methods.
For biomanufacturing, in GCRI's spatial-intelligence reading, the map opens on crop greenness, population density, daytime surface heat and true-colour imagery, framed on West Africa; 2 further NASA layers wait in the list.
The interactive map needs JavaScript; the layer list and sources are below.
Layers 4
Environmental exposure, for this page
Keyboard, with the map focused
Hold Ctrl or ⌘ and scroll to zoom
Latest available
NASA GIBS / EOSDIS · ASTER GDEM (METI, NASA) · Blue Marble (NASA) · © OpenStreetMap contributors (ODbL) · Natural Earth
Loading the latest NASA imagery.
Drag to move. Ctrl or ⌘ and scroll, pinch or the buttons to zoom; hover for the values under the pointer; reset returns to the region.
For biomanufacturing, in GCRI's spatial-intelligence reading, the map opens on crop greenness, population density, daytime surface heat and true-colour imagery, framed on West Africa; 2 further NASA layers wait in the list.Satellite and model products as NASA publishes them, each with its own date; indicators, not assessments of any place; claim ceiling INTEGRATED.
Layers and dates
The working screen behind this subject: its structure, terms and states. Names are placeholders and values illustrative.
Biomanufacturing · National committee · Review year 3
| Institution A | Active | Q2 | 90 | Current |
| Research campus | Active | Q2 | 71 | Audit due |
| Biomanufacturing site | Forming | none | 44 | Support |
| Diagnostic network | Active | Q2 | 82 | Current |
Biomanufacturing replaces chemical synthesis or extraction with biological production in fermenters and bioreactors. Scaling up is difficult because living systems behave differently at larger volumes, and processes depend on precise control of temperature, nutrients and sterility. Quality failures can halt production for long periods, and regulatory approval of manufacturing sites takes time.
Capacity for many essential products, including vaccines and key inputs, is concentrated in a small number of facilities and countries. During health emergencies, demand rises sharply while supply chains for reagents, single-use equipment and specialized staff tighten. Process safety disciplines, described in process and industrial safety engineering, address the hazards of large-scale biological and chemical operations.
Biomanufacturing also changes the geography of risk. Distributed, smaller facilities could reduce dependence on a few sites and shorten supply chains, but they spread the need for skilled staff, quality systems and biosafety oversight across many more locations. Feedstocks such as sugars and agricultural residues link production to food and land markets, so the sector's growth has consequences for agriculture as well as industry.
Engineering and process safety methods from process and industrial safety engineering assess hazards, containment and reliability.
Studies trace capacity, inputs and single points of failure for essential products.
Environmental accounting compares biomanufactured products with conventional alternatives.
Facility data is commercially confidential, scale-up outcomes are uncertain, and life-cycle results depend heavily on assumptions about energy and feedstocks.
Each term as this page uses it. Where a standard-setting body defines the term, the wording follows that body.
| Term | Definition |
|---|---|
| Process safety | The management of hazards in facilities handling dangerous substances to prevent major accidents. |
| Single-source dependence | Reliance of an assertion on one source, however often it is cited. |
| Biosafety | Measures that assess and manage risks to health and the environment from living modified organisms, governed internationally by the Cartagena Protocol. |
| Supply chain resilience | The ability of a supply chain to anticipate, absorb, adapt to and recover from disruptions while continuing to deliver, which OECD work on supply chains examines through diversification and stocks. |
This evidence informs industrial policy, emergency preparedness planning, investment in distributed capacity and regulatory practice for manufacturing sites. Governments, manufacturers, health agencies and regulators decide. The governance of preparedness is convened by Health and Biosecurity Governance at The Global Risks Forum (GRF). Related topics are synthetic biology, diagnostics and therapeutics and agricultural biotechnology; methods sit on biotechnology platforms and process and industrial safety engineering.
Published analysis on this topic is designed to carry a named subject reviewer, its references and the views of independent specialists, including biosafety professionals and those who disagree.
The current service level is R0: information and enquiries. An enquiry receives a reference and names the next step; applications, payments, compute allocations and registrations open only when their team, terms and review capacity exist.